hematopoietic system
|
• decreased lymphocyte proliferation due to anti-CD3 + anti-CD28
|
|
• impaired splenocyte proliferation in response to concanavalin A, lipopolysaccharide, or to PMA + ionomycin
|
|
• light but significant drop in proportion of T cells
• fewer cells in S phase
|
|
• deficient T cell cytolytic effect
|
immune system
|
• decreased lymphocyte proliferation due to anti-CD3 + anti-CD28
|
|
• impaired splenocyte proliferation in response to concanavalin A, lipopolysaccharide, or to PMA + ionomycin
|
|
• light but significant drop in proportion of T cells
• fewer cells in S phase
|
|
• deficient T cell cytolytic effect
|
|
• decreased secretion of Il-4 due to decreased GTP levels
• Il-2 levels remain more or less normal
|
cellular
|
• decreased lymphocyte proliferation due to anti-CD3 + anti-CD28
|
|
• impaired splenocyte proliferation in response to concanavalin A, lipopolysaccharide, or to PMA + ionomycin
|